Results 171 to 180 of about 5,534,789 (298)

Time, the final frontier

Molecular Oncology, EarlyView.
This article advocates integrating temporal dynamics into cancer research. Rather than relying on static snapshots, researchers should increasingly consider adopting dynamic methods—such as live imaging, temporal omics, and liquid biopsies—to track how tumors evolve over time.
Gautier Follain, Michal Dibus, Omkar Joshi, Guillaume Jacquemet   +3 more
wiley   +1 more source

"You do it to cover your own back": The assessment of cervical spine radiculopathy among physiotherapists in the United Kingdom: A mixed methods research study. [PDF]

PLoS One
Mansfield M, Jong ST, Smith T.
europepmc   +1 more source

Yellow fever resurgence: An avoidable crisis?

npj Vaccines, 2022
Nicole P. Lindsey, Jennifer Horton, Alan D. T. Barrett, Maurice Demanou, Thomas P. Monath, Oyewale Tomori, Michel Van Herp, Herve Zeller, Ibrahima Soce Fall, Laurence Cibrelus, J. Erin Staples   +10 more
doaj   +1 more source

Studies on the Assessment of Egg Production in Poultry Breeding Investigations

, 1954
F. Skaller
openalex   +1 more source

Clinical Assessment of the Treponemal Wassermann Reaction [PDF]

, 1959
E M Dunlop, I. N. O. Price
openalex   +1 more source

Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry

Molecular Oncology, EarlyView.
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson, Emma L. Dorward, Kristyn Jurrius, Nathalie Nataren, Markus Tondl, Kay K. Myo Min, Michaelia P. Cockshell, Anahita Fouladzadeh, John Toubia, Mark DeNichilo, Delphine Merino, Claudine S. Bonder   +11 more
wiley   +1 more source

Cross-Cultural Paediatric Neuropsychological Assessment: Key Considerations. [PDF]

Health Sci Rep
O'Donald F, Calia C, Franzen S.
europepmc   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

Molecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu, Ning Ding, Xiaobo Xu, Yedan Chen, Yong Zhang, Jingwen Liu, Jiebai Zhou, Hairong Bao, Donghui Zhang, Yijun Song, Yang Shao, Yuanlin Song   +11 more
wiley   +1 more source

Evaluation of Subjective Assessment of Right Heart Size and Function Using Standard 2D-Echocardiographic Recordings in Horses With and Without Pulmonary Hypertension. [PDF]

J Vet Intern Med
van Spijk JN, Junge HK, Eberhardt C, Wolf N, Vogt D, Zscherpe P, Herger E, Straub M, Schwarzwald CC.   +8 more
europepmc   +1 more source

State Supervision of County Assessment and Taxation [PDF]

, 1913
JOHN E. BRINDLEY
openalex   +1 more source